Panel Recommends More Testing for Diabetes Drugs
The U.S. Food and Drug Administration should require pharmaceutical companies to conduct studies examining the effect of new diabetes drugs on the heart, an advisory committee recommended Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article